Whitfield Roy A

Director

1 company

Whitfield Roy A is a Director at NKTR. Recent filings cover 4 purchases and 1 sale. Those positions are worth an estimated $16.5M at current prices.

Whitfield Roy A's largest disclosed position is in NKTR as Director, worth about $16.5M. Net of sales, the recent Form 4 record there shows accumulation of 10,000 shares.

Holdings by Company

NKTRJun 14, 2023

Current Shares216.3K

Value$16.54M

Net Activity+10.0K

Bought: 40.0KSold: 30.0K

Transaction History

Showing 3 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 14, 2023	NKTR Nektar Therapeutics	Director	Sell	30,000	$0.57	$17,100.00	-12.2%	+19.6%	+126.9%
Jun 6, 2018	NKTR Nektar Therapeutics	Director	Buy	5,000	$58.04	$290,212.00	+1.0%	-	-
Aug 10, 2017	NKTR Nektar Therapeutics	Director	Buy	35,000	$17.95	$628,250.00	+35.7%	-	-

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →SEC Form 4 Lookup: How to Find and Search Insider Trading Filings →What is Insider Trading? A Complete Guide →